← Feed

Schwab Andrew J.

SEC Form 4 insider
Skye Bioscience, Inc. ($SKYE), Camp4 Therapeutics Corp ($CAMP)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CAMPSEC Form 4bearish
Schwab Andrew J. · Camp4 Therapeutics Corp · 3h agono track record yet
Sold 191,865 @ $4.59 avg · $879,719 · 2026-08-19

Form 4: Schwab Andrew J. sold CAMP

Schwab Andrew J. (Director at Camp4 Therapeutics Corp) reported an open-market sale of 191,865 shares of CAMP at an average $4.59, roughly $879,719, in a Form 4 filed 2026-08-21.

View filing on SEC.gov →

End of results.